| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.89 | 0.0001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.2 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.18 | 0.2 |